Sutro Biopharma (STRO) PT Raised to $35 at Citizens Ahead of AACR Conference
Tweet Send to a Friend
Citizens analyst Reni Benjamin raised the price target on Sutro Biopharma (NASDAQ: STRO) to $35.00 (from $23.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
